Biodexa Pharmaceuticals BDRX
NASDAQ BDRX
$1.26 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

Biodexa Pharmaceuticals (BDRX) Interest Expenses (2013 - 2025)

Biodexa Pharmaceuticals (BDRX) posted Interest Expenses of -$180096.2 for Q2 2025, down 186.36% sequentially from -$62891.6 in Q4 2024.

Biodexa Pharmaceuticals (BDRX) Interest Expenses (2013 - 2025) Analysis & Trends

Biodexa Pharmaceuticals has reported Interest Expenses for 12 years, with the latest figure at -$180096.2 in Q2 2025.

  • Quarterly Interest Expenses changed N/A year-over-year to -$180096.2 in Q2 2025, while the trailing twelve-month figure through Dec 2025 was -$242987.8 (down 168.73% YoY) and the FY2025 annual result came in at -$301938.9, down 242.57% from the prior year.
  • Interest Expenses declined to -$180096.2 in Q2 2025 per BDRX's latest filing, from -$62891.6 in the prior quarter.
  • Over five years, Interest Expenses peaked at -$27530.0 in Q2 2023 and troughed at -$216759.6 in Q3 2021.
  • A 5-year average of -$107914.1 and a median of -$62891.6 in 2024 frame the typical range for Interest Expenses.
  • The sharpest annual moves came in 2021 and 2022: Interest Expenses slumped 682.41% in 2021, then jumped 86.61% in 2022.
  • Over 5 years, Interest Expenses stood at -$210289.7 in 2021, then surged by 86.61% to -$28150.3 in 2022, then climbed by 2.2% to -$27530.0 in 2023, then sank by 128.45% to -$62891.6 in 2024, then tumbled by 186.36% to -$180096.2 in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods registered -$180096.2, -$62891.6, and -$27530.0 for Q2 2025, Q4 2024, and Q2 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 11.00 Mn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 39.74 Mn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 82.05 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 20.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn - 93.62 Mn
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -4.89 Mn
10 Biodexa Pharmaceuticals 63,168.17 -11.29 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -304,608.06
Dec 31, 2025 -304,608.06
Jun 30, 2025 -180,096.17
Jun 30, 2025 -180,096.17
Dec 31, 2024 -62,891.59
Dec 31, 2024 -62,891.59
Jun 30, 2023 -27,529.99
Jun 30, 2023 -27,529.99
Dec 31, 2022 -28,150.28
Dec 31, 2022 -28,150.28
Sep 14, 2022 -29,681.42
Sep 14, 2022 -29,681.42
Dec 31, 2021 -210,289.65
Dec 31, 2021 -210,289.65
Sep 17, 2021 -216,759.65
Sep 17, 2021 -216,759.65
Dec 31, 2020 -569,114.38
Dec 31, 2020 -569,114.38
Sep 10, 2020 -27,704.17
Sep 10, 2020 -27,704.17